MCID: STR008
MIFTS: 52

Strongyloidiasis malady

Categories: Rare diseases, Infectious diseases, Gastrointestinal diseases

Aliases & Classifications for Strongyloidiasis

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 36MeSH, 2CDC, 65UMLS, 27ICD10, 29ICD9CM, 59SNOMED-CT, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Strongyloidiasis:

Name: Strongyloidiasis 10 45 47 12 51 36 2 65
Disseminated Strongyloidiasis 10 65
Anguilluliasis 51 65
Infection by Strongyloides 10
 
Threadworm Infection 45
Anguillulosis 51
Enterobiasis 65

Characteristics:

Orphanet epidemiological data:

51
strongyloidiasis:
Inheritance: Not applicable; Age of onset: All ages

Classifications:



External Ids:

Disease Ontology10 DOID:10955
ICD1027 B78, B78.9, B78.7
ICD9CM29 127.2
MeSH36 D013322
Orphanet51 76
ICD10 via Orphanet28 B78.0, B78.1, B78.7 B78.9, more
MESH via Orphanet37 D013322
UMLS via Orphanet66 C0038463
UMLS65 C0038463, C0348996, C0086227 C0085810, more

Summaries for Strongyloidiasis

About this section
NIH Rare Diseases:45 Strongyloidiasis is a parasitic disease caused by the roundworm strongyloides stercoralis (s. stercoralis). people catch the infection when they come in contact with soil contaminated with the worms. while there are often no symptoms, abdominal pain, cough, diarrhea, rash, unintentional weight loss and vomiting may occur. the infection is treated with anti-worm medications such as ivermectin. strongyloidiasis is found in tropical and subtropical areas, but can also be found in temperate regions, including the southern united states. last updated: 9/20/2010

MalaCards based summary: Strongyloidiasis, also known as disseminated strongyloidiasis, is related to opisthorchiasis and asthma, and has symptoms including pruritus An important gene associated with Strongyloidiasis is IL5 (Interleukin 5), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and IgA-Producing B Cells in the Intestine. The drugs albendazole and mebendazole have been mentioned in the context of this disorder. Affiliated tissues include skin, lung and testes, and related mouse phenotype tumorigenesis.

Disease Ontology:10 A parasitic helminthiasis infectious disease that involves infection of the intestine, lungs, skin and central nervous system with nematode Strongyloides stercoralis.

CDC:2 Strongyloidiasis was first described in French troops stationed in modern day Vietnam during the late 19th century who were suffering from severe, persistent diarrhea. It is a parasitic disease caused by nematodes, or roundworms, in the genus Strongyloides that enter the body through exposed skin, such as bare feet. Strongyloides is most common in tropical or subtropical climates.

Wikipedia:68 Strongyloidiasis is a human parasitic disease caused by the nematode (roundworm) called Strongyloides... more...

Related Diseases for Strongyloidiasis

About this section

Diseases related to Strongyloidiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 167)
idRelated DiseaseScoreTop Affiliating Genes
1opisthorchiasis29.4CD79A, IFNG, TGFB1
2asthma28.1CCL11, CD79A, IFNG, IL5, TGFB1
3eosinophilic granulomatosis with polyangiitis10.5IFNG, IL5
4limbic encephalitis with ncmags antibodies10.5IFNG, IL5
5gonococcal bursitis10.5IFNG, IL5
6chronic demyelinizing neuropathy with igm monoclonal10.4IFNG, TGFB1
7hepatoid adenocarcinoma10.4IFNG, IL5
8blepharophimosis10.4CCL11, IL5
9papillary conjunctivitis10.4CCL11, IL5
10bacterial gastritis10.4CCL11, IL5
11antley-bixler syndrome with genital anomalies and disordered steroidogenesis10.4CCL11, IL5
12loeffler syndrome10.4CCL11, IL5
13superficial urinary bladder cancer10.4CCL11, IL5
14eosinophilic gastroenteritis10.4CCL11, IL5
15granulomatous amebic encephalitis10.4CD79A, IL5
16motor peripheral neuropathy10.4CCL11, IL5
17impetigo herpetiformis10.4CD79A, IL5
18exudative glomerulonephritis10.4CD79A, TGFB1
19female breast central part cancer10.4CD79A, IL5
20tuberculoid leprosy10.4IFNG, TGFB1
21toxic diffuse goiter10.4CD79A, TGFB1
22central nervous system childhood germ cell tumor10.4CCL11, IL5
23familial hyperlipidemia10.4CCL11, IL5
24retroperitoneal germ cell neoplasm10.4CCL11, IL5
25beriberi10.4CD79A, IFNG
26disseminated eosinophilic collagen disease10.4CCL11, IL5
27goat milk allergy10.4CD79A, TGFB1
28balkan nephropathy10.4CCL11, IL5
29chronic hiccups10.3CD79A, IFNG
30palindromic rheumatism10.3CD79A, TGFB1
31amyotrophic lateral sclerosis type 210.3CD79A, IFNG
32acute gonococcal epididymo-orchitis10.3IFNG, IL5
33leech infestation10.3IFNG, TGFB1
34cystic echinococcosis10.3CD79A, TGFB1
35opioid abuse10.3CCL11, IL5
36collagenous colitis10.3CD79A, IFNG
37nasopharyngitis10.3CCL11, IL5
38argentine hemorrhagic fever10.3CD79A, IFNG
39b cell deficiency10.3CD79A, IFNG
40hodgkin's lymphoma, nodular sclerosis10.3CD79A, IL5
41vulvovaginitis10.3CD79A, IFNG
42inhalation anthrax10.3CD79A, TGFB1
43reflex sympathetic dystrophy10.3IFNG, TGFB1
44soft palate cancer10.3CD79A, IFNG
45food allergy10.3IFNG, IL5
46bronchopulmonary dysplasia10.3IFNG, TGFB1
47chronic eosinophilic pneumonia10.3CCL11, IL5
48hodgkin's lymphoma, lymphocytic-histiocytic predominance10.3IFNG, IL5
49cryoglobulinemia10.3CD79A, IFNG
50keshan disease10.3CD79A, IFNG

Graphical network of the top 20 diseases related to Strongyloidiasis:



Diseases related to strongyloidiasis

Symptoms for Strongyloidiasis

About this section

UMLS symptoms related to Strongyloidiasis:


pruritus

Drugs & Therapeutics for Strongyloidiasis

About this section

Drugs for Strongyloidiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AlbendazoleapprovedPhase 37254965-21-82082
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
Albendazole
Albendazole (JAN/USP/INN)
Albendazole Armstrong Brand
Albendazole Diba Brand
Albendazole Fustery Brand
Albendazole Hormona Brand
Albendazole Liferpal Brand
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole Pfizer Brand
Albendazole Sanicoopa Brand
Albendazole Valdecasas Brand
Albendazole [USAN:INN:BAN:JAN]
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
BIDD:GT0615
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
Bendapar
Bilutac
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
CID2082
CPD000036735
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
ChemDiv1_000190
ChemDivAM_000003
D00134
D015766
DB00518
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
HSDB 7444
Hormona Brand of Albendazole
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
 
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
LS-50618
Liferpal Brand of Albendazole
Lurdex
MLS000069722
Mediamix V Disthelm
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
NSC 220008
NSC220008
Noe Socopharm Brand of Albendazole
Noe-Socopharm Brand of Albendazole
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer Brand of Albendazole
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Prestwick_675
Proftril
Ricobendazole
Rycobendazole
S1640_Selleck
SAM002589939
SK&F 62979
SK&F-62979
SK&F62979
SKF 62979
SKF-62979
SKF62979
SMR000036735
SPBio_002253
SPECTRUM1503903
STK387550
STL046130
STOCK2S-67946
Sanicoopa Brand of Albendazole
Smith Kline & French Brand of Albendazole
SmithKline Beecham Brand of Albendazole
Spectrum4_000201
Spectrum5_001567
Spectrum_001532
TL8003543
UNII-F4216019LN
V Disthelm, Mediamix
VU0239747-6
Valbazen
Valdecasas Brand of Albendazole
ZINC17146904
Zental
Zentel
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
albendazole
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
2
IvermectinapprovedPhase 34770288-86-76474909, 46936176
Synonyms:
(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
22,23-Dihydroxy-avermectin B
22,23-Dihyroavermectin B1
5-O-Demethyl-22,23-dihydro-avermectin A1a
71827-03-7
AB00513813
AC1MJ4GR
AC1N7O27
BPBio1_000322
BRD-K24652731-001-02-7
BSPBio_000292
CHEMBL341047
CID11957587
CID4330618
CID6321424
CID6419971
CID6427057
EU-0100693
FT-0082656
HMS1568O14
HMS2089M09
I 8898
 
I8898_SIGMA
IVERMECTIN
Ivermectin
Ivermectina
Ivermectine
Ivermectinum
Lopac0_000693
MK-933
MLS001333247
MLS001333248
MLS002153248
MolPort-006-394-715
NCGC00094047-01
NCGC00094047-02
NCGC00094047-03
Prestwick2_000156
Prestwick3_000156
Prestwick_516
S1351_Selleck
SMR000857211
Sklice
Soolantra
Stromectol
3Anti-Infective AgentsPhase 317220
4Tubulin ModulatorsPhase 34279
5Antimitotic AgentsPhase 34296
6Antiprotozoal AgentsPhase 31730
7Antiparasitic AgentsPhase 31854
8AnthelminticsPhase 3379
9
Piperazineapproved22110-85-04837
Synonyms:
1,4-Diazacyclohexane
1,4-Diethylenediamine
1,4-Piperazine
110-85-0
14007-05-7 (unspecified hydrobromide)
142-63-2 (hexahydrate)
142-64-3 (di-hydrochloride)
14538-56-8 (phosphate[1:1])
16832-43-2 (unspecified hydrate)
1951-97-9 (unspecified phosphate)
3597-26-0 (unspecified sulfate)
5-23-01-00030 (Beilstein Handbook Reference)
6094-40-2 (unspecified hydrochloride)
7542-23-6 (mono-hydrochloride)
8017-90-1
8027-81-4
8057-14-5 (unspecified salt)
80621_FLUKA
854880-15-2
861800-35-3
AB1003720
AC1L1J2E
AC1Q1IA7
AC1Q1IA8
AC1Q1IA9
AKOS000269028
AR-1L1009
ARONIS23910
Anthalazine
Antiren
Asca-Trol No. 3
BIDD:GT0273
BRN 0102555
C07973
CCRIS 5950
CHEBI:28568
CHEMBL1412
CID4837
D00807
DB00592
Diethylenediamine
Diethyleneimine
Dispermine
DivK1c_000038
EINECS 203-808-3
Eraverm
Eraverm (VAN)
Fluphenazine dihydrochloride
HMS1920H20
HMS2092A03
HMS500B20
HSDB 1093
Hexahydro-1,4-diazine
Hexahydropyrazine
I14-11172
IDI1_000038
InChI=1/C4H10N2/c1-2-6-4-3-5-1/h5-6H,1-4H
Jsp000824
KBio1_000038
KBio2_001593
KBio2_004161
KBio2_006729
KBioSS_001593
LS-517
LTBB000432
Lumbrical
MolPort-000-872-010
NCGC00094762-01
NCGC00094762-02
NCIOpen2_000984
NCIOpen2_000988
NCIOpen2_001024
NCIOpen2_001031
NCIOpen2_001033
NCIOpen2_001071
NCIOpen2_001073
 
NCIOpen2_001111
NCIOpen2_001151
NCIOpen2_001231
NCIOpen2_001262
NCIOpen2_001269
NCIOpen2_004830
NCIOpen2_004834
NCIOpen2_004862
NCIOpen2_004874
NCIOpen2_004904
NCIOpen2_004910
NCIOpen2_004914
NCIOpen2_004942
NCIOpen2_004952
NCIOpen2_004954
NCIOpen2_004982
NCIOpen2_004992
NCIOpen2_004994
NCIOpen2_005022
NCIOpen2_005032
NCIOpen2_005034
NCIOpen2_005062
NCIOpen2_005072
NCIOpen2_005102
NCIOpen2_005108
NCIOpen2_005145
NCIOpen2_005182
NCIOpen2_005185
NCIOpen2_005187
NCIOpen2_005200
NCIOpen2_005575
NCIOpen2_005980
NCIOpen2_009422
NINDS_000038
NSC 474
NSC474
P0446
P0447
P45907_SIAL
PIPERAZINE (HEXAHYDRATE)
PZE
Piperazidine
Piperazin
Piperazin [German]
Piperazin [Germany]
Piperazine
Piperazine (USP)
Piperazine Dihydrochloride Dihydrochloride Hydrate
Piperazine Hexa-Hydrate
Piperazine [UN2579] [Corrosive]
Piperazine [UN2579] [Corrosive]
Piperazine [USAN]
Piperazine anhydrous
Piperazine citrate
Piperazine hexahydrate
Piperazine hydrate
Piperazine, anhydrous
Pipersol
Pyrazine hexahydride
Pyrazine, hexahy
SPECTRUM1500490
Spectrum5_001817
Spectrum_001113
UN2579
UNII-1RTM4PAL0V
Upixon
Uvilon
Vermex
Vermizine
Vermizine (TN)
Vermizine (tn)
WLN: T6M DMTJ
Worm-A-Ton
Worm-away
Wurmirazin
nchembio814-comp12
piperazine
piperazinium oleate
10
Mebendazoleapproved2231431-39-74030
Synonyms:
(5-Benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
(5-Benzoyl-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Benzoyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
(5-benzoyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester
2-Benzimidazolecarbamic acid, 5-benzoyl-, methyl ester (8CI)
31431-39-7
46404_FLUKA
46404_RIEDEL
5-Benzoyl-2-benzimidazolecarbamic acid methyl ester
5-Benzoyl-2-benzimidazolecarbamic acid, methyl ester
AB00052203
AC-12064
AC1L1H98
AC1Q44DR
AKOS000539066
Abello Farmacia Brand of Mebendazole
Anti Worm
Anti-Worm
Ardeypharm Brand of Mebendazole
BAS 00341140
BIDD:GT0087
BPBio1_000257
BRD-K77987382-001-01-7
BRD-K77987382-001-06-6
BSPBio_000233
BSPBio_003178
Bantenol
Banworm
Besantin
Bio-0458
Bio-0803
Boots Brand of Mebendazole
Boots Threadworm Treatment
CAS-31431-39-7
CBDivE_010559
CCRIS 4479
CHEBI:6704
CHEMBL685
CID4030
CPD000036734
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester
Carbamic acid, (5-benzoyl-1H-benzimidazol-2-yl)-, methyl ester (9CI)
Carbamic acid, N-(5-benzoylbenzimidazol-2-yl)-, methyl ester
D00368
D008463
DB00643
Degort's Brand of Mebendazole
Diba Brand of Mebendazole
DivK1c_000751
EINECS 250-635-4
Elfar Brand of Mebendazole
Equivurm Plus
Esteve Brand of Mebendazole
HMS1536H11
HMS1568L15
HMS1921F03
HMS2090B03
HMS2092B15
HMS502F13
HSDB 3232
Healthypharm Brand of Mebendazole
I06-2075
IDI1_000751
Janssen Brand of Mebendazole
KBio1_000751
KBio2_001778
KBio2_004346
KBio2_006914
KBio3_002398
KBioGR_000712
KBioSS_001778
LS-48951
Leidapharm Brand of Mebendazole
Lomper
M2523_FLUKA
M2523_SIGMA
MBDZ
MEBENDAZOLE, 99%
MLS000028491
Madicure
Mebendan
Mebendazol
Mebendazol [INN-Spanish]
Mebendazole
Mebendazole (JAN/USP)
 
Mebendazole (JAN/USP/INN)
Mebendazole [USAN:INN:BAN:JAN]
Mebendazole(USAN)
Mebendazolum
Mebendazolum [INN-Latin]
Mebenoazole
Mebenvet
Mebex
Mebutar
Methyl 5-benzoyl benzimidazole-2-carbamate
Methyl 5-benzoyl-2-benzimidazolecarbamate
Methyl 5-benzoyl-2-benzimidazolylcarbamate
Methyl N-(5-benzoyl-1H-benzimidazol-2-yl)carbamate
Methyl N-(5-benzoyl-2-benzimidazolyl)carbamate
MolPort-000-765-625
MolPort-001-889-615
Mébendazole
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle
N-(Benzoyl-5, benzimidazolyl)-2, carbamate de methyle [French]
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle
N-2 (5-Benzoyl-benzimidazole) carbamate de methyle [French]
NCGC00016806-01
NCGC00016806-02
NCGC00021698-03
NCGC00021698-04
NCGC00021698-05
NCGC00021698-06
NINDS_000751
NSC 184849
NSC184849
Norgine Brand of Mebendazole
Noverme
Oprea1_278237
Oprea1_768530
Ovitelmin
Pantelmin
Pfizer Brand of Mebendazole
Prestwick0_000217
Prestwick1_000217
Prestwick2_000217
Prestwick3_000217
Prestwick_310
Pripsen Mebendazole
Probes1_000013
Probes2_000149
R 17,635
R 17635
R-17635
R17635
SAM002548959
SMR000036734
SPBio_001442
SPBio_002154
SPECTRUM1501110
SSL Brand of Mebendazole
STK093862
Spectrum2_001401
Spectrum3_001439
Spectrum4_000416
Spectrum5_001381
Spectrum_001298
Sqworm
Streger Brand of Mebendazole
Sufil
Surfont
TL8002405
Taxandria Brand of Mebendazole
Tedec Meiji Brand of Mebendazole
Telmin
TimTec1_000869
UNII-81G6I5V05I
Vermicidin
Vermicol
Vermidil
Vermin
Vermirax
Vermox
Vermox (TN)
Verpanyl
Versid
Wormkuur
ZINC00121541
mebendazole
methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-1,3-benzodiazol-2-yl)carbamate
methyl N-(6-benzoyl-1H-benzimidazol-2-yl)carbamate
methyl [5-(phenylcarbonyl)-1H-benzimidazol-2-yl]carbamate
11
Diethylcarbamazineapproved1190-89-13052
Synonyms:
1-Diethylcarbamyl-4-methylpiperazine
12672-34-3
1642-54-2 (citrate (1:1))
4-23-00-00225 (Beilstein Handbook Reference)
5348-97-0
5348-97-0 (mono-hydrochloride)
8028-18-0
84L
90-89-1
AB00053457
AC1L1F2E
AI3-19612
AKOS003268016
BPBio1_000208
BRD-K45542189-048-05-6
BRN 0143029
BSPBio_000188
BSPBio_002179
Bitirazine
C07968
CHEMBL684
CID3052
Camin
Camin (TN)
Caracide
Carbamazine
Carbilazine
Caricide
Cypip
D07825
DB00711
Decacide
Diaethylcarbamazinum
Diethyl carbamazine
Diethylcarbamazin
Diethylcarbamazine (INN)
Diethylcarbamazine Citrate
Diethylcarbamazine [INN:BAN]
Diethylcarbamazinum
Diethylcarbamazinum [INN-Latin]
 
Dietilcarbamazina
Dietilcarbamazina [INN-Spanish]
Ditrazine Base
Ditrazine base
DivK1c_000548
Diéthylcarbamazine
EINECS 202-023-3
Ethodryl
FR-1031
IDI1_000548
KBio1_000548
KBio2_001418
KBio2_003986
KBio2_006554
KBio3_001399
KBioGR_001081
KBioSS_001418
LS-110688
Luxuran
MolPort-001-788-448
N,N-Diethyl-4-methyl-1-piperazinecarboxamide
N,N-diethyl-4-methylpiperazine-1-carboxamide
NCGC00178778-01
NCGC00178778-02
NINDS_000548
NSC1364
Notezine
Prestwick0_000284
Prestwick1_000284
Prestwick2_000284
Prestwick3_000284
SPBio_001203
SPBio_002407
Spatonin
Spectrum2_001022
Spectrum3_000390
Spectrum4_000511
Spectrum5_000877
Spectrum_000938
UNII-V867Q8X3ZD
diethylcarbamazine
12
Formaldehydeexperimental7350-00-0712
Synonyms:
Aldeide formica
Fannoform
Formaldehyde
Formalina
Formaline
Formalith
Formic aldehyde
Formol
 
Methaldehyde
Methanal
Methyl aldehyde
Methylene glycol
Methylene oxide
Oxomethane
Oxomethylene
Oxymethylene
Paraform
Paraformaldehyde
13Piperazine citrate22
14Ether52

Interventional clinical trials:

idNameStatusNCT IDPhase
1Multiple Versus Single Dose of Ivermectin for the Treatment of StrongyloidiasisRecruitingNCT01570504Phase 3
2Ivermectin Versus Albendazole for Chronic StrongyloidiasisEnrolling by invitationNCT00765024Phase 3
3Study of Patients With Strongyloides Stercoralis InfectionCompletedNCT00001245
4Effectiveness of Combined Albendazole and Ivermectin Treatment for Intestinal Worm InfectionsCompletedNCT00207753
5The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon IslandsCompletedNCT01080989
6Management of Soil-transmitted Helminthiasis and StrongyloidiasisRecruitingNCT01308268
7Host Response to Infection and Treatment in Lymphatic Filarial Disease in IndiaRecruitingNCT00342576
8Parasitic Infections of the Gastrointestinal TractRecruitingNCT00001162
9Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive DisordersActive, not recruitingNCT02105714

Search NIH Clinical Center for Strongyloidiasis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: strongyloidiasis

Genetic Tests for Strongyloidiasis

About this section

Anatomical Context for Strongyloidiasis

About this section

MalaCards organs/tissues related to Strongyloidiasis:

33
Skin, Lung, Testes, T cells, Prostate, B cells, Breast

Animal Models for Strongyloidiasis or affiliated genes

About this section

MGI Mouse Phenotypes related to Strongyloidiasis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.7CD79A, IFNG, IL5, TGFB1

Publications for Strongyloidiasis

About this section

Articles related to Strongyloidiasis:

(show top 50)    (show all 563)
idTitleAuthorsYear
1
Megaduodenum associated with gastric strongyloidiasis. (25951613)
2015
2
Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy. (25925183)
2015
3
Update on immunologic and molecular diagnosis of human strongyloidiasis. (24686097)
2014
4
Strongyloidiasis hyperinfection in a patient with a history of systemic lupus erythematosus. (25092815)
2014
5
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. (23592987)
2013
6
Strongyloidiasis presenting as larva currens 38 years after presumed exposure. (23149200)
2012
7
Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin. (22975175)
2012
8
A series on intestinal strongyloidiasis in immunocompetent and immunocompromised hosts. (23025061)
2012
9
IgG avidity in differential serodiagnosis of human strongyloidiasis active infection. (21699917)
2011
10
Uncomplicated strongyloidiasis in a liver transplant recipient on steroid-free immunosuppression. (20487417)
2010
11
Pulmonary strongyloidiasis. (20329418)
2009
12
Identification of a 26-kDa protein fraction as an important antigen for application in the immunodiagnosis of strongyloidiasis. (17569087)
2007
13
IgG1, IgG4, and IgE antibody responses in human strongyloidiasis by ELISA using Strongyloides ratti saline extract as heterologous antigen. (17610082)
2007
14
Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up. (17135451)
2007
15
Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma. (17641892)
2007
16
Strongyloidiasis stercoralis: is it a health problem in Saudi Arabia? (17366869)
2006
17
Intestinal strongyloidiasis and common variable immunodeficiency syndrome. (15876606)
2005
18
Cutaneous periumbilical purpura in disseminated strongyloidiasis in cancer patients: a pathognomonic feature of potentially lethal disease? (16410894)
2005
19
Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock. (16041520)
2005
20
Severe gastrointestinal strongyloidiasis. (16082494)
2005
21
Successful ivermectin treatment of hepatic strongyloidiasis presenting with severe eosinophilia. (15455986)
2004
22
Pulmonary strongyloidiasis presenting as chronic bronchitis leading to interlobular septal fibrosis and cured by treatment. (14708557)
2003
23
Strongyloides venezuelensis alkaline extract for the diagnosis of human strongyloidiasis by enzyme-linked immunosorbent assay. (14595467)
2003
24
Strongyloidiasis and natural killer cell lymphocytosis. (10809888)
2000
25
Pulmonary strongyloidiasis--case report of 2 cases. (10969524)
2000
26
High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. (11042682)
2000
27
Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies). (10096585)
1999
28
Parasite-specific serum IgG following successful treatment of endemic strongyloidiasis using ivermectin. (9015524)
1996
29
Fulminant, systemic strongyloidiasis in AIDS. (8758145)
1996
30
Expression of CD23, CD32, Mac-1 and other adhesion molecules in eosinophils in strongyloidiasis and HTLV-I-positive patients. (8906113)
1996
31
Interrelation of strongyloidiasis and tuberculosis. (8063205)
1994
32
Strongyloides stercoralis: the first rodent model for uncomplicated and hyperinfective strongyloidiasis, the Mongolian gerbil (Meriones unguiculatus). (8245532)
1993
33
Fatal adult respiratory distress syndrome following successful treatment of pulmonary strongyloidiasis. (1995245)
1991
34
Aphthoid ulceration of the colon in strongyloidiasis. (2028960)
1991
35
Gelatin particle indirect agglutination test for mass examination for strongyloidiasis. (1755062)
1991
36
Strongyloidiasis associated with human T-cell lymphotropic virus type I infection in a nonendemic area. (2588581)
1989
37
Diagnosis of pulmonary strongyloidiasis by bronchoalveolar lavage. (3409752)
1988
38
Endemic institutional strongyloidiasis in British Columbia. (3607675)
1987
39
Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. (2886441)
1987
40
Seroepidemiology of strongyloidiasis in a Thai village. (3429125)
1987
41
Concentrations of thiabendazole and parasite-specific IgG antibodies in the cerebrospinal fluid of a patient with disseminated strongyloidiasis. (3611836)
1987
42
Indigenous strongyloidiasis in Nottingham. (3109595)
1987
43
Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. (3711300)
1986
44
Risk factors for strongyloidiasis. A case-control study. (6696569)
1984
45
Cambendazole in the treatment of human strongyloidiasis. (6625071)
1983
46
Immunological features in different clinical forms of strongyloidiasis. (6623593)
1983
47
Pulmonary strongyloidiasis. (7063915)
1982
48
Strongyloidiasis and chronic urticaria. (7111108)
1982
49
Transmission of strongyloidiasis by kidney transplant? Disseminated strongyloidiasis in both recipients of kidney allografts from a single cadaver donor. (7026811)
1981
50

Variations for Strongyloidiasis

About this section

Expression for genes affiliated with Strongyloidiasis

About this section
Search GEO for disease gene expression data for Strongyloidiasis.

Pathways for genes affiliated with Strongyloidiasis

About this section

Pathways related to Strongyloidiasis according to GeneCards Suite gene sharing:

(show all 14)
idSuper pathwaysScoreTop Affiliating Genes
19.7IL5, TGFB1
29.7IL5, TGFB1
39.6IFNG, IL5
49.6IFNG, IL5
5
Show member pathways
9.6IFNG, TGFB1
69.6IFNG, TGFB1
79.6IFNG, TGFB1
89.6IFNG, TGFB1
99.6CCL11, IL5
109.2IFNG, IL5, TGFB1
119.1CCL11, IFNG, IL5
129.1CD79A, IFNG, IL5
13
Show member pathways
8.7CCL11, IFNG, IL5, TGFB1
14
Show member pathways
8.7CD79A, IFNG, IL5, TGFB1

GO Terms for genes affiliated with Strongyloidiasis

About this section

Biological processes related to Strongyloidiasis according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1negative regulation of interleukin-17 productionGO:003270010.3IFNG, TGFB1
2cell cycle arrestGO:000705010.1IFNG, TGFB1
3positive regulation of peptidyl-tyrosine phosphorylationGO:005073110.1IL5, TGFB1
4protein import into nucleus, translocationGO:000006010.1IFNG, TGFB1
5response to virusGO:00096159.9CCL11, IFNG
6extrinsic apoptotic signaling pathwayGO:00971919.8IFNG, TGFB1
7neutrophil chemotaxisGO:00305939.7CCL11, IFNG
8positive regulation of transcription, DNA-templatedGO:00458939.6IFNG, IL5, TGFB1
9positive regulation of cell proliferationGO:00082849.2IFNG, IL5, TGFB1
10inflammatory responseGO:00069549.2CCL11, IL5, TGFB1
11immune responseGO:00069558.8CCL11, IFNG, IL5

Sources for Strongyloidiasis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet